of the involvement of the macrophage migration inhibitory factor-glucocorticoid regulatory dyad in the expression of matrix metalloproteinase-2 during periodontitis. Eur J Oral Sci 2017; 125: 345-354. © 2017 Eur J Oral Sci Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine and counter-regulator of endogenous glucocorticoids (GCs). It is implicated in acute and chronic inflammatory diseases. This study investigated the role of the MIF-GC regulatory dyad in the expression and release of matrix metalloproteinase-2 (MMP-2) during periodontitis, in vivo and in vitro. In a Mif-knockout (KO) mouse model of ligature-induced periodontitis, gingival tissues and blood were collected and analysed for levels of interleukin-6 (IL-6), MIF, MMP-2, and corticosterone. In addition, human gingival fibroblasts (HGFs) were tested for production of IL-6 and MMP-2 after stimulation with hydrocortisone (HC), MIF, tumour necrosis factoralpha (TNF-a), or Fusobacterium nucleatum, a pathogen known to elicit immune responses during periodontitis. Wild-type (WT) mice showed a local and systemic increase of MIF levels during inflammation, which was confirmed by increased local IL-6 concentrations. Systemic GC levels were reduced in WT and Mif-KO mice during inflammation, with overall lower concentrations in Mif-KO mice. In vivo and in vitro, MMP-2 production was not dependent on MIF or inflammatory stimuli, but was inhibited by HC. Therefore, MIF does not appear to stimulate expression of MMP-2 in the gingival tissues, whereas GC upregulates MIF and downregulates MMP-2. Our findings further suggest that MIF may regulate systemic GC levels.
Macrophage migration inhibitory factor (MIF), a proinflammatory mediator, plays a critical role in chronic and acute inflammatory diseases. Importantly, MIF is known to be the main counter-regulator of endogenous anti-inflammatory glucocorticoids (GCs), which are produced by the adrenal glands. For this reason, MIF has been classified as both a hormone and a cytokine (1) . T cells were the cells first reported to be potent producers of MIF (2) . In further studies, the pituitary gland was also found to be a source of systemic MIF in response to inflammation, such as sepsis (3) . Later, other leukocytes and fibroblasts were found to produce MIF (4) , which elicited a variety of proinflammatory responses in inflamed tissues by upregulating other proinflammatory cytokines, such as interleukin-6 (IL-6) (5). In addition, MIF is also implicated in the progression of several systemic inflammatory diseases, including rheumatoid arthritis (RA), atherosclerosis, and diabetes mellitus, by lowering systemic cortisol levels (6) (7) (8) (9) (10) .
Periodontitis, triggered by pathogenic bacteria such as Fusobacterium nucleatum, is a chronic and destructive inflammatory disease of the tooth-supporting tissues (11) . In periodontitis, MIF was shown to promote osteoclastogenesis, thereby enhancing periodontal bone loss in an animal model (12) . While MIF is known to be expressed in periodontital lesions, its impact on softtissue degradation remains elusive. However, in other chronic inflammatory diseases, such as RA, MIF is known to upregulate matrix metalloproteinases (MMPs) which cause soft-tissue breakdown (5) . Several reports suggest that MMP-2 promotes tissue destruction in periodontitis (13) (14) (15) (16) . More specifically, MMP-2 was found to participate in the degradation of extracellular matrixes, such as type I and type IV collagen, laminin-332, and versican, which play a pivotal role in connecting the junctional epithelium to the tooth surface (17) (18) (19) (20) .
To obtain a better understanding of the role of MIF in regulating MMP-2-mediated tissue degradation, a mouse model of ligature-induced periodontitis, as well as in vitro approaches using stimulated gingival fibroblasts (HGFs), were employed. As MIF and endogenous GC constitute a functional dyad, the contribution of GC to MMP-2 release was also investigated.
Material and methods

Animals
Six male C57BL/6J wild-type (WT) mice and six male C57BL/6J Mif-knockout (Mif-KO) mice were used in this study. The WT mice were obtained from The Jackson Laboratories (Bar Harbor, ME, USA) (stock number 000664). The Mif-KO mice were produced as described previously (21) and were generously provided by Dr Abhay Satoskar (Ohio State University, Columbus, OH, USA) as homozygotes, backcrossed to a C57BL/6J background. The number of mice used was in accordance with, or exceeded, the number employed in previously published studies that used Mif-KO mice in the context of periodontitis or MMP-2 research (12, 22) . All mice were kept as previously described (23) and were 6-wk-old when the experiments were conducted. All procedures involving mouse experiments were approved by the Institutional Animal Care and Use Committee at The Forsyth Institute, Cambridge, MA, USA.
Model of ligature-induced periodontitis
For all mice, a 5-0 braided silk ligature (PERMA-HAND; Ethicon, Somerville, NJ, USA) was placed around the upper-left secondary molar. Ligatures are thought to facilitate local accumulation of bacteria and thereby enhance bacteria-mediated inflammation and bone loss (24) . Ligature placement was performed under general anaesthesia. Ketamine-xylazine in sterile saline was injected once, intraperitoneally, at a dose of 100 mg kg À1 of ketamine and 10 mg kg À1 of xylazine. The ligature-placement procedure took 5 to 10 min per mouse, and a surgical microscope and metal clamps were used to keep the mice's mouths open. The right maxillary side was left untreated, and ligatures were kept in place on the upper-left secondary molar for 9 d. Eating and drinking behaviour was monitored and did not change in the mice following ligature placement.
Sample collection
Blood was drawn at 19.00 h on days 0 and 9 in order to avoid the influence of circadian fluctuations of GC levels. Whole blood (0.5 ml) was collected from the retro-orbital area, allowed to clot for 20 min to obtain serum, and centrifuged at 2,000 g for 10 min at 4°C. Supernatants were either assessed immediately or stored at À20°C until completion of the study. After 9 d of ligature placement, mice were killed with CO 2 gas by trained personnel. Subsequently, the gingival tissues surrounding the upper right and left secondary molars were collected and immediately frozen in liquid nitrogen. Total RNA was extracted from the gingival tissues using TRIzol reagent (Life Technologies, Carlsbad, CA, USA) for PCR, or the tissue samples were stored at À80°C for 1 wk.
Cell culture
Primary HGFs were harvested from five periodontally healthy donors, as described by DAMANKI et al. (25) , after obtaining written informed consent and approval of the Ethics Committee of the University of Bonn (#043/11). The HGFs were cultured separately in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) at 37°C in a 5% CO 2 atmosphere. All cell-culture assays were performed five times as biological replicates for each experimental condition. For experimental procedures, the medium was changed to 1% FCS and cells were seeded into separate 24-well tissue-culture plates at a density of 5 9 10 5 cells and allowed to adhere overnight. Next, MIF (20 ng ml À1 ), hydrocortisone (HC) (100 lg ml À1 ) (Sigma Aldrich, Schnelldorf, Germany), or tumour necrosis factor-alpha (TNF-a) (20 ng ml
À1
) were added to the experimental wells. Tumour necrosis factoralpha is a potent and ubiquitous stimulator of inflammation and therefore served as a positive control (26) . As a negative control, cells incubated with PBS were used. The concentrations used were based on those commonly described in the literature and verified by previous assays determining concentration-dependent release of MIF and MMP-2 (27) (28) (29) . To mimic bacterial infection, HGFs were inoculated with F. nucleatum (ATCC 10953) at a multiplicity of infection (MOI) of 1:10. Fusobacterium nucleatum is a pathogenic anaerobe that is found in human periodontal pockets. It is associated with periodontitis and elicits a strong immune response in host cells (11) . Human T cells (Jurkat cells) were used as a positive control because they are known to release high levels of MIF (2) . All cells were incubated for 12 h at 37°C in a 5% CO 2 atmosphere. Subsequently, supernatants were collected and stored at À20°C until further use, whereas adherent cells were lysed and total RNA was obtained using TRIzol reagent (Life Technologies, Darmstadt, Germany). All cell-culture experiments were performed at the University Hospital Bonn.
PCR
Total RNA from mouse gingival tissues and HGFs was converted into cDNA (iScript cDNA synthesis kit; Bio-Rad, Hercules, CA, USA) using 1 lg of total RNA by addition of RT (0.5 ll) in a total solution of 20 ll. Mouse cDNA was analysed by quantitative PCR (qPCR) and human cDNA by RT-PCR. The custom primer sets used for murine tissues were company-designed and tested for Actb (b-actin), Il-6, Mif (Qiagen QuantiTect, Valencia, CA, USA), and Mmp-2 (Real Time Primers, Elkins Park, PA, USA) mouse genes. qPCR was performed using a LightCycler 480 system with LightCycler 480 SYBR Green I Master Mix (Roche Applied Science, Branford, CT, USA) for 50 cycles. The PCR cycling profile consisted of an initial denaturation step at 95°C for 5 min, followed by 50 cycles of (i) denaturation at 95°C for 15 s and (ii) annealing/extension at 58-60°C for 60 s. Melting curve analysis was also performed applying 95°C for 20 s, 60°C for 20 s, and increasing the temperature to 95°C with 0.2°/sec. The primers applied to HGF cDNA for RT-PCR were designed using the NCBI Primer-BLAST tool and purchased from Thermo Fisher (Darmstadt, Germany). Primer sequences for the glyceraldehyde-3-phosphate dehydrogenase (GADPH) reference gene (NCBI accession number: NM_002046), for a product length of 218 bp, were forward (5 0 ? 3 0 ) TCCCTGAGCTGAACG GGAAG and reverse (5 0 ? 3 0 ) GGAGGAGTGGGTG TCGCTGT (annealing temperature 64°C). The sequences for human MMP-2 (NCBI accession number: NM_0011 27891), for a product length of 293 bp, were forward (5 0 ? 3 0 ) ACTCCTGGCTCATGCCTTC and reverse (5 0 ? 3 0 ) GCGTTCCCATACTTCACACG (annealing temperature 59°C). Thirty-five cycles were run for each PCR amplification and, after gel elctrophoresis, bands were visualized using ethidium bromide.
Elisa
Serum samples were assessed for corticosterone (murine cortisol) by competitive ELISA (Oxford Biomedical Research, Rochester Hills, MI, USA). The MIF levels in serum samples and tissue lysates were measured using the Mouse MIF DuoSet ELISA (R&D Systems, Minneapolis, MN, USA). Human gingival fibroblast supernatants were analysed by ELISA to measure the levels of MMP-2 and IL-6 (Boster Bio, Pleasanton, CA, USA) and MIF (CloudClone, Houston, TX, USA). All ELISA procedures were carried out according to the protocols provided by the manufacturers.
Gelatin zymography
To assess whether MMP-2 was secreted from HGFs as an active enzyme or as a proenzyme, gelatin zymography was conducted. Cell-culture supernatatants were collected, and the total protein concentration was enhanced by filtering samples using Vivaspin 4 concentrators with a pore size of 10,000 molecular weight cut-off (Sartorius Stedim Biotech, Stonehouse, UK). Total protein was measured using the BCA assay (Life Technologies). SDS gels containing 20 mg ml À1 of gelatin (Merck Millipore, Darmstadt, Germany) were prepared, and PAGE was performed under non-reducing conditions, after addition of 20 lg ml À1 of sample into each well. Subsequently, gels were stained with 0.05% Coomassie Brilliant Blue G250 (Merck Millipore) for 2 h and destained for 2 h in deionized water containing 8% acetic acid and 4% methanol. Destained bands were recorded using a Gel Doc XR+ system (Bio-Rad, Hercules, CA, USA).
Image processing
Images were acquired using Gene Tools image analysis software (Syngene, Frederick, MD, USA). Image J Fiji (National Insititutes of Health, Bethesda, MD, USA) was used for further image analysis and data quantification after performing PCR and gelatin zymography.
Statistical analysis
A post-hoc power analysis was conducted to determine the power (53%, P = 0.05) of the MMP-2-related outcomes in WT and KO mice for the observed effect size of d = 1.3, using G*POWER software (Version 1.3) (30) . Relative gene expression was determined by applying the DDC T calculation method, using b-actin as a control. Unpaired unequal variance t-tests were employed to calculate statistically significant differences between two groups. Paired unequal variance t-tests were applied for comparison of the means of two related groups on the same dependent variable. Quantification of PCR and zymography bands was statistically evaluated using one-way ANOVA and posthoc Tukey's test. Values of P ≤ 0.05 were considered statistically significant. All data are shown as mean AE SD.
Results
Confirmation of MIF deficiency in Mif-KO mice
To confirm the MIF-KO phenotype, DNA genotyping was performed. In addition, gingival tissues were subjected to RT-PCR and analysed for the presence of Mif mRNA, and serum was analysed by ELISA for the presence of MIF protein. Genotyping, RT-PCR, and ELISA showed no evidence of MIF in the KO mice (data not shown).
MIF is not involved in the upregulation of local IL-6 in periodontitis
To confirm inflammation, murine gingival tissues and in vitro cell cultures were assessed for expression of the Il-6 gene and quantities of IL-6 protein, respectively, as this cytokine is known to be significantly enhanced in periodontal lesions (31, 32) . Nine days after ligature placement, local tissue mRNA levels of Il-6 were markedly higher in inflamed tissues (0.006 AE 0.002 in WT mice and 0.005 AE 0.002 in KO mice) than in the control non-ligatured sites in both mouse groups (0.003 AE 0.001 in WT mice and 0.0005 AE 0.0002 in KO mice) (Fig. 1A) , confirming the presence of inflammation. A more pronounced fold change was seen in inflamed tissues of Mif-KO mice (10-fold) compared with WT mice (two-fold), indicating that IL-6 was induced by endogenous stimuli other than MIF under inflammatory conditions (Fig. 1B) . To investigate, in more detail, the in vivo findings at the cellular level, an in vitro model of infected human gingival fibroblasts, the most abundant cell type in the gingival tissues, was employed. Increases in IL-6 could also be observed in HGFs after stimulation with F. nucleatum (618.7 AE 220.2 pg ml À1 ) compared with the negative control (115.7 AE 45.1 pg ml À1 ) (Fig. 1C) .
MIF levels are increased and corticosterone levels are decreased during inflammation
Expression of Mif mRNA was increased two-fold in inflamed sites compared with healthy sites of WT mice (P = 0.03). The levels of MIF protein in serum and in gingival tissues were significantly higher during inflammation (Table 1) . Notably, we observed an overall higher expression of the Mif gene in relation to Actb compared with Il-6 (see Fig. 1 and Table 1 for comparison), indicating that Mif may be produced in larger quantities in response to local inflammation. The amount of MIF protein released from HGF cells was inducible by HC (9.5 AE 0.26 ng ml À1 vs. 4.9 AE 0.66 ng ml À1 in unstimulated HGFs), but not by TNF-a or F. nucleatum (Fig. 2) , and was overall higher (nanogram range) than that of IL-6 (picogram range), consolidating the observation that MIF may be produced in larger quantities than IL-6. Corticosterone levels decreased during inflammation (136.1 AE 50.1 ng ml À1 on day 9 vs. 186.5 AE 32.5 ng ml À1 on day 0 in WT mice) and were overall lower in Mif-KO mice (42.9 AE 27.7 ng ml À1 on day 9 vs. 91.7 AE 21.2 ng ml À1 on day 0) (Fig. 3) , suggesting that corticosterone release may be MIF dependent.
MMP-2 expression in gingival tissues is independent of MIF As shown in Fig. 4A , the levels of Mmp-2 mRNA in both WT and Mif-KO mice did not change (Fig. 4B) ; however, it was significantly suppressed by HC (unstimulated HGFs: 0 AE 0.29 ng ml À1 vs. 8.3 AE 0.58 ng ml
À1
). Expression of MMP-2 mRNA in HGFs in response to different stimuli was confirmed by RT-PCR (Fig. 5A,B) : the sample containing HC showed a weaker band intensity, indicating its suppression of the MMP-2 gene [0.64 AE 0.03 AU vs. 1.00 AE 0.05 arbitrary units (AU) in unstimulated HGFs]. Gelatin zymography confirmed that most of the MMP-2 released was active (two-fold higher than pro-MMP-2 in unstimulated controls) (Fig. 6A,B) . Also, a significantly higher level of active MMP-2 was released from HGFs stimulated with F. nucleatum compared with . Grey bars, wild-type (WT) mice (n = 6); white bars, macrophage migration inhibitory factor knockout (Mif-KO) mice (n = 6). Results are shown as mean AE SD; each sample was run in duplicate. (A) *P = 0.05, **P = 0.006 for healthy vs. inflamed tissues in WT mice and in Mif-KO mice and (B) **P = 0.01 for inflamed sites in WT mice vs. inflamed sites in Mif-KO mice. (C) Levels of IL-6 released from human gingival fibroblasts (HGFs) after stimulation with hydrocortisone (HC), MIF, or Fusobacterium nucleatum. *P ≤ 0.05 compared with the negative control (neg. ctrl.). As a positive control (pos. ctrl.), tumour necrosis factor-alpha (TNF-a), which is known to induce release of IL-6 (64), was employed. The results are shown as mean AE SD and represent five different donors; each sample was run in triplicate.
unstimulated HGFs (75.4 AE 5.7 AU vs. 61.6 AE 2.95 AU), whereas less activation of MMP-2 was found in the sample containing HC (44.5 AE 1.66 AU), supporting the findings from the MMP-2 ELISA.
Discussion
Macrophage migration inhibitory factor is a key proinflammatory mediator released during local and systemic inflammation (1) . Our experiments were aimed at investigating whether MIF has an influence on the expression and release of MMP-2 in gingival tissues during inflammation. A Mif-KO mouse model, as well as cellculture experiments, were employed using stimulated HGFs, which are the most abundant structural cells in gingival tissues (33) . This study revealed higher expression of MIF in inflamed periodontal tissue and in HGFs when compared with IL-6, as well as increased levels of MIF in the systemic circulation. However, we could not verify a correlation between MIF and MMP-2 in periodontal inflammation. PAKOZDI and colleagues previously demonstrated a significant increase of MMP-2 expression in synovial fibroblasts in response to MIF during experimental RA in mice (22) . Rheumatoid arthritis and periodontitis are thought to be corelated chronic inflammatory diseases, both developing in a progressive manner if left untreated (34) . Interestingly, MMP-2 may have a protective function in RA, which was shown by two independent studies (35, 36), Table 1 Local and systemic presence of macrophage migration inhibitory factor (MIF) in vivo and in vitro suggesting that MMP-2 could counterbalance MIF to prevent the excessive immune response in RA. Although the underlying mechanism for the protective role of MMP-2 in RA has not been established, it is known that MMP-2 can cleave the proinflammatory cytokine interleukin-1beta (IL-1b) and monocyte chemoattractant protein 3 (37), thus exhibiting an antiinflammatory effect. However, in periodontitis, MMP-2 is known to be destructive to humans and rodents (15, 16) . Although MIF was upregulated during periodontitis, locally and systemically, in our study, we found that it did not influence expression of MMP-2 in vivo and in vitro, suggesting that the effects of MIF on local MMP-2 production are different in RA and periodontitis. Notably, HGFs released MMP-2 without any external stimulus, but also upon stimulation, we observed no change in the release of MMP-2. This confirms the findings of other studies which report that MMP-2 is constitutively expressed by fibroblasts and other cell types, but is not upregulated during gingival inflammation (38, 39) . A post-hoc power analysis was conducted in order to determine the power to detect differences between the MMP-2 levels in the two groups of mice and between healthy and inflamed tissues. Power was calculated with 53% for the observed effect size (d = 1.3). Thus, we cannot completely rule out that a small or medium-sized effect of MIF deficiency on MMP-2 levels remained undetected in our study. In order to identify medium-size MIF-dependent alterations (d = 0.7) of MMP-2 production in vivo at a power of 80%, larger animal cohorts (n = 34 per group) need to be included in future studies.
Interleukin-6, used as a marker of local inflammation in our study, showed a significantly higher fold change during inflammation in Mif-KO mice compared with WT mice. It is possible that MIF deficiency leads to a compensatory upregulation of IL-6 and other proinflammatory mediators during inflammation, as described previously (40, 41) . Furthermore, HGFs were stimulated with F. nucleatum, a pathogenic anaerobe that is found in human periodontal pockets and elicits a strong immune response in host cells. We found that F. nucleatum could directly upregulate proinflammatory IL-6 in HGFs, presumably via toll-like receptors (TLRs) 2 or 4 (38), both of which have been previously detected on the cell surface of HGFs (42) . Upregulation of IL-6 was observed in both animal models and cellculture experiments, indicating that oral bacteria accumulating in the area of ligature placement may contribute to the release of IL-6 from murine HGFs via the TLR signalling cascade.
Macrophage migration inhibitory factor is a key modulator of endogenous GCs. According to CALAN-DRA & BUCALA, MIF is the first mediator to be identified that can directly counter-regulate the immune-inhibitory effects of GCs and thus plays a critical role in the host's control of inflammation and immunity (43) . More specifically, MIF counteracts the anti-inflammatory effects of GC at the cellular level, whereas GC can induce release of MIF from the pituitary gland and from macrophages (44, 45) . This process is concentration-dependent and is thought to control excessive or insufficient immune responses (46) . In our experiments, a coherence between MIF and GC was also detectable: interestingly, in Mif-KO mice significantly less systemic corticosterone was observed, and in both groups the levels decreased during inflammation. Although it is well known that stress, which may occur under experimental conditions, increases corticosterone levels in mice, it is also established that C57BL/6 mice are relatively stress-resistant (47, 48) . Furthermore, all mice were handled and housed in an identical manner, yet these differences in systemic cortisol levels were highly significant. Moreover, the fact that the level of corticosterone decreased over time indicates that stress was not a contributory factor. Taken together, these findings support that systemic cortisol induces MIF release, as described in numerous previous studies (1, 49) , and that MIF, in contrast, may be involved in GC induction (Fig. 7) . Enhancement of corticosterone by MIF has, to our knowledge, not been reported in the literature; therefore, this theory requires further investigation to confirm this putative function.
In our experiments, we stimulated HGFs with HC, an exogenous GC, in order to assess its effects on MMP-2 release. The results from MMP-2 ELISA, RT-PCR, and zymography showed a reduction of both protein and gene expression levels of MMP-2. These findings are supported by those of a previous study and corroborate the anti-inflammatory role of GCs, suggesting that HC may help to decrease the local tissue destruction mediated by MMP-2 (50). Compared with other GCs, HC has properties very similar to those of endogenous cortisone. For this reason, HC was chosen for our cell-culture experiments. Other GCs, such as dexamethasone, also feature immunosuppressive properties and were reported to decrease the release of MMP-2 from host cells (51, 52) . Several GCs were shown to affect MIF production; however, the data are discordant regarding their ability to up-or downregulate MIF (45, (53) (54) (55) (56) .
It is important to note that ligature-induced periodontitis in mice does not correlate perfectly with the onset and long-term development of the disease in humans. However, our in vivo mouse model, combined with an in vitro model of stimulated HGFs, may help to provide a better understanding of the involvement of MIF in periodontal inflammation. Importantly, this study investigated the expression of MMP-2, not other MMPs or tissue inhibitors of matrix metalloproteinases (TIMPs). These could be addressed in future studies in order to gain further insight into the role of MIF in tissue degradation during periodontitis. Matrix metalloproteinase-2 is secreted into the extracellular environment; however, pro-MMP-2 can be released or remain bound to membrane-type 1 MMP and membrane-type tissue inhibitor of metalloproteinases-2 (TIMP-2) (35, 57) . Therefore, our zymography assays were confined to the measurement of released pro-MMP-2 only. For a more accurate determination of the ratio between MMP-2 and pro-MMP-2, cell-culture supernatants, as well as cell-membrane preparations, should be used in future detection assays.
As a further limitation of this study, HGFs were infected with F. nucleatum only, whereas periodontal inflammation is caused by an array of microbial species living in a biofilm community. However, F. nucleatum is a dominant microorganism within human oral biofilms and is found at increased levels in periodontal disease (11) . Moreover, F. nucleatum has been reported to induce more significant changes in cultured cells than other microbial inducers of periodontitis (58, 59) and is known to play a pivotal role in biofilm formation (60) . Mice were not infected with F. nucleatum; therefore, the underlying pathobiological mechanisms of periodontitis induction may have been different. As F. nucleatum is naturally found in the murine oral cavity (61) and experimental periodontitis is thought to be induced by the local accumulation of bacteria around the ligature (24), F. nucleatum may have been present in the periodontitis lesions of our mouse model. Supernatants of F. nucleatum-stimulated HGFs showed enhanced gelatinolytic activity in the zymography assays. The increased digestion of gelatin by supernatants obtained from HGFs stimulated with F. nucleatum corresponded to the increased levels of MMP-2 released in this study, and the proteolytic band coincided with the known size of MMP-2 protein.
Although the potential of F. nucleatum proteases to degrade gelatin has been demonstrated (62), our own experiments using F. nucleatum only for gelatin zymography did not show detectable gelatinase activity. However, this may have been a result of the low concentrations of bacteria (5 9 10 6 per well) used in this assay. Notably, F. nucleatum has been reported to convert pro-MMP-9 into the proteolytically active form (63); thus, it is possible that F. nucleatum may have similar effects on pro-MMP-2. Little is known about proteases expressed by F. nucleatum and their ability to degrade host tissues; therefore, future studies may be aimed at investigating these as a potential pathomechanism in periodontal tissue breakdown.
In conclusion, the results of this study indicate that MIF may be involved in the upregulation of systemic GC in mice, as Mif-KO mice had overall lower levels of corticosterone. Furthermore, we demonstrated inhibition of MMP-2 production by GC. However, our findings do not support the modification of local MMP-2 concentrations by MIF. Moreover, production of MMP-2 appears to be differentially regulated by MIF in RA and periodontitis. Fig. 7 . Summary of the putative roles of macrophage migration inhibitory factor (MIF), glucocorticoid (GC), and matrix metalloproteinase-2 (MMP-2) in periodontal inflammation. It is well established that MIF enhances inflammation (A), while GCs dampen the immune response (B). However, GCs may evoke MIF release (C) (1 and 45), which then counteracts the anti-inflammatory effects of GC (D). The findings of the present study support a proinflammatory role of MIF in periodontal inflammation. However, a direct relationship between MIF and MMP-2, which is thought to have a destructive role in periodontitis (E), could not be detected (F). Instead, MIF seemed to increase systemic GC levels in mice (G), and hydrocortisone (HC), an exogenous GC, was able to diminish release of MMP-2 (H). We hypothesize that systemic MIF and GC can promote the release of one another, but that MIF may not play a relevant role in MMP-2 induction in periodontal inflammation.
